Immune to Cancer: The CRI Blog
-
Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo
Dr. Allison’s discoveries and determination led to the development of the first FDA-approved checkpoint immunotherapy
-
Former CRI Grantee Dr. Lieping Chen Named a “2018 Giant of Cancer Care in Immuno-Oncology”
Dr. Lieping Chen's work helped pave the way for the development of the PD-1/PD-L1 checkpoint immunotherapies that…
-
AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells
Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…
-
Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs
Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…
-
CRI Congratulates 2016 Lasker Award Winners
The Albert and Mary Lasker Foundation announced the 2016 recipients of the prestigious Lasker Awards, and CRI congratulates Charles…
-
CRI Scientist Receives Russian Federation National Award
Sergei Nedospasov, PhD, D.Sc., was honored for his contributions to the molecular mediators of immunity, including work…
-
#AACR16 Update: The Cancer Research Institute’s Impact on Immunotherapy
Since our founding in 1953, the Cancer Research Institute has pioneered the field of cancer immunology, and… -
CRI Scientific Advisory Council Member Elected NAI Fellow
Pramod K. Srivastava, MD, PhD, a CRI Scientific Advisory Council member, was elected a Fellow in the National…
-
CRI’s James Allison to Receive Prestigious Lasker Award
The Lasker Foundation announced today that James P. Allison, PhD, director of CRI’s Scientific Advisory Council, is…